Found 5 matching trials
Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies
PHASE2This is a phase II, single arm, unblinded study of ceritinib in patients wi...
Location
Duke University Medical Center
Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
EARLY_PHASE1This is two parallel studies to examine pharmacokinetic (PK), pharmacodynam...
Location
Barrow Brain and Spine
LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib.
PHASE2This was a single-arm, open-label, multicenter, phase II study to evaluate ...
Location
Novartis Investigative Site
A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
PHASE2Lung cancer is the most leading cause of cancer-related mortality worldwide...
Location
Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
PHASE2ROS1 is a receptor tyrosine kinase with constitutive kinase activity. ROS1 ...
Location
Yonsei Cancer Center at Yonsei University Medical Center